Wound Care Market

Executive Summary

Wound Care Market was valued at US $10.07 billion in 2021 and is projected to grow at 7.10% CAGR over the forecast period to reach US $15.19 billion by 2027. Wound Care Market represented US $1.29 billion opportunity over 2019-2021 and estimated to create US $5.12 billion opportunity in 2027 over 2021.

Wound Care from Consainsights analyses the Wound Care Market in the Life Sciences industry over the forecast period to 2027.

Wound Care research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Wound Care segmentation includes Product, Wound Type, End-user and Geography.

Based on the Product, the Wound Care analysis covers Advanced Wound Care Products, Surgical Wound Care Products, Traditional Wound Care Products.

In Product segment, Advanced Wound Care Products segment has highest cagr growth of 6.28%.

Based on the Wound Type, the Wound Care analysis covers Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burns & Other Wounds.

In Wound Type segment, Surgical & Traumatic Wounds segment has highest cagr growth of 6.28%.

Based on the End-user, the Wound Care analysis covers Hospitals & Clinics, Home Care Settings, Long-Term Care Facilities, Other End-users.

In End-user segment, Hospitals & Clinics segment has highest cagr growth of 6.28%.

Based on the region, the Wound Care analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Smith & Nephew plc, Cardinal Health, Medtronic plc, B. Braun Melsungen AG, Baxter International Inc., Mölnlycke Health Care AB, Convatec Group, Paul Hartmann AG, Coloplast A/S, Organogenesis Holdings Inc., MiMedX Group, Integra Lifesciences Holdings Corporation, Misonix, Zimmer Biomet Holdings Inc., Ethicon Inc., Deroyal Industries, Kerecis, ACell, Lohmann & Rauscher International GmbH & Co. KG, Medela AG, Talley Group, Welcare Industries S.p.A., Wuhan VSD Medical Science & Technology Co. Ltd., Pensar Medical, Haromed BVBA, Dermarite Industries LLC, Medline Industries, Inc., Advancis Medical LLC, Mil Laboratories Pvt. Ltd. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Advanced Wound Care Products segment has the highest revenue of US $3.82 billion and is expected to grow at CAGR of 6.28% by 2027 Advanced Wound Care Products segment has highest cagr growth of 6.28%.

Advanced Wound Care Products

Advanced Wound Care Products segment was valued at US $3.33 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $5.77 billion by 2027. Advanced Wound Care Products segment represented US $0.49 billion opportunity over 2019-2021 and estimated to create US $1.94 billion opportunity in 2027 over 2021.

Surgical Wound Care Products

Surgical Wound Care Products segment was valued at US $3.27 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $5.65 billion by 2027. Surgical Wound Care Products segment represented US $0.48 billion opportunity over 2019-2021 and estimated to create US $1.91 billion opportunity in 2027 over 2021.

Traditional Wound Care Products

Traditional Wound Care Products segment was valued at US $2.18 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $3.77 billion by 2027. Traditional Wound Care Products segment represented US $0.32 billion opportunity over 2019-2021 and estimated to create US $1.27 billion opportunity in 2027 over 2021.

Wound Type

Introduction

In 2021, Surgical & Traumatic Wounds segment has the highest revenue of US $3.70 billion and is expected to grow at CAGR of 6.28% by 2027 Surgical & Traumatic Wounds segment has highest cagr growth of 6.28%.

Surgical & Traumatic Wounds

Surgical & Traumatic Wounds segment was valued at US $3.22 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $5.58 billion by 2027. Surgical & Traumatic Wounds segment represented US $0.47 billion opportunity over 2019-2021 and estimated to create US $1.88 billion opportunity in 2027 over 2021.

Diabetic Foot Ulcers

Diabetic Foot Ulcers segment was valued at US $2.60 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $4.50 billion by 2027. Diabetic Foot Ulcers segment represented US $0.38 billion opportunity over 2019-2021 and estimated to create US $1.52 billion opportunity in 2027 over 2021.

Pressure Ulcers

Pressure Ulcers segment was valued at US $1.73 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $2.99 billion by 2027. Pressure Ulcers segment represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.01 billion opportunity in 2027 over 2021.

Venous Leg Ulcers

Venous Leg Ulcers segment was valued at US $0.71 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $1.22 billion by 2027. Venous Leg Ulcers segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.41 billion opportunity in 2027 over 2021.

Burns & Other Wounds

Burns & Other Wounds segment was valued at US $0.52 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $0.89 billion by 2027. Burns & Other Wounds segment represented US $0.08 billion opportunity over 2019-2021 and estimated to create US $0.30 billion opportunity in 2027 over 2021.

End-user

Introduction

In 2021, Hospitals & Clinics segment has the highest revenue of US $3.62 billion and is expected to grow at CAGR of 6.28% by 2027 Hospitals & Clinics segment has highest cagr growth of 6.28%.

Hospitals & Clinics

Hospitals & Clinics segment was valued at US $3.16 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $5.47 billion by 2027. Hospitals & Clinics segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $1.84 billion opportunity in 2027 over 2021.

Home Care Settings

Home Care Settings segment was valued at US $2.83 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $4.89 billion by 2027. Home Care Settings segment represented US $0.42 billion opportunity over 2019-2021 and estimated to create US $1.65 billion opportunity in 2027 over 2021.

Long-Term Care Facilities

Long-Term Care Facilities segment was valued at US $1.78 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $3.08 billion by 2027. Long-Term Care Facilities segment represented US $0.26 billion opportunity over 2019-2021 and estimated to create US $1.04 billion opportunity in 2027 over 2021.

Other End-users

Other End-users segment was valued at US $1.01 billion in 2019 and is projected to grow at 6.28% CAGR over the forecast period to reach US $1.75 billion by 2027. Other End-users segment represented US $0.15 billion opportunity over 2019-2021 and estimated to create US $0.59 billion opportunity in 2027 over 2021.